Madison Avenue Partners, LP — INDIVIOR PHARMACEUTICALS INC INDV: Quarterly 13F Position History
Madison Avenue Partners, LP has reported INDIVIOR PHARMACEUTICALS INC (INDV) on 2 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2025. As of Q1 2026, the position is sized at 4,315,162 shares ($131.5M market value, 5.72% of the equity book). Quarter-over-quarter share count change: 1,965,340 (-31.3%) .
- 4,315,162Shares Held (Latest Filing)
- $131.5MReported Market Value (Latest Filing)
- 5.72%Portfolio Weight (% of 13F Equity Book)
- 1,965,340Quarter-over-Quarter Share Change
- -$93.8MQuarter-over-Quarter Value Change
- 6,280,502Peak Reported Shares (Historical)
Recent initiation: Madison Avenue Partners, LP first reported INDV on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 4,315,162 | 1,965,340 | -31.3% | $131.5M | 5.72% | $30.48 |
| Q4 2025 | 6,280,502 | — | — | $225.3M | 9.68% | $35.88 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Madison Avenue Partners, LP first disclose a INDV position in 13F-HR filings?
Madison Avenue Partners, LP first reported INDIVIOR PHARMACEUTICALS INC (INDV) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Madison Avenue Partners, LP's most recent quarter-over-quarter share-count change in INDV?
Between Q4 2025 and Q1 2026, Madison Avenue Partners, LP reduced its INDV position by 1,965,340 shares (-31.3%), leaving 4,315,162 shares at a market value of $131.5M.
Does the implied price-per-share represent Madison Avenue Partners, LP's cost basis in INDV?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.